Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation

International Journal of Neuropsychopharmacology

Volumn 17, Issue 5, 2014, Pages 779-791

  Musazzi, L ^a   Rimland, J M ^b   Ieraci, A ^a   Racagni, G ^a   Domenici, E ^b   Popoli, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b GSK   (Italy)

Author keywords

Antidepressant; BDNF promoter; gene reporter; neuronal culture

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; MONOAMINE; NORADRENALIN; REBOXETINE; SEROTONIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; LITHIUM CARBONATE; MORPHOLINE DERIVATIVE; SEROTONIN AGONIST;

ANIMAL CELL; ARTICLE; BDNF PROMOTER 1; BDNF PROMOTER 2; BDNF PROMOTER 4; BRAIN CELL CULTURE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DEPRESSION; DISSOCIATED CELL CULTURE; EXON; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION INITIATION; ANIMAL; BRAIN CORTEX; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; RAT;

ADRENERGIC AGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; FLUOXETINE; HIPPOCAMPUS; LITHIUM CARBONATE; MORPHOLINES; NEURONS; NOREPINEPHRINE; PROMOTER REGIONS, GENETIC; RATS; SEROTONIN; SEROTONIN RECEPTOR AGONISTS; TRANSCRIPTIONAL ACTIVATION;

EID: 84897419197     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713001685     Document Type: Article

References (61)

1. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450-453
2. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525-535
3. Alboni S, Benatti C, Capone G, Corsini D, Caggia F, Tascedda F, Mendlewicz J, Brunello N (2010) Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats. Eur J Pharmacol 643:180-187
4. Baj G, D'Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, Tardito D, Langone F, Popoli M, Tongiorgi E (2012) Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: Further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacol 37:1600-1611
5. Birkenhäger TK, Geldermans S, Van Den Broek WW, van Beveren N, Fekkes D (2012) Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression. J Psychiatr Res 46:285-289
6. Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35:567-576
7. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA (2007) Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacol 32:2351-2359
8. Carlezon WA Jr., Duman RS, Nestler EJ (2005) The many faces of CREB. Trends in Neurosci 28:436-445
9. Castrén E, Võikar V, Rantamäki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21
10. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265
11. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885-889
12. Chiaruttini C, Sonego M, Baj G, Simonato M, Tongiorgi E (2008) BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Mol Cell Neurosci 37:11-19
13. DeVane CL (1999) Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 19:443-466
14. Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003) Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacol 45:553-563
15. Donnici L, Tiraboschi E, Tardito D, Musazzi L, Racagni G, Popoli M (2008) Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells. BMC Neurosci 9:61
16. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127
17. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804-815
18. Dwivedi Y, Rizavi HS, Pandey GN (2006) Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: Differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139:1017-1029
19. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311-7316
20. Gärtner A, Collin L, Lalli G (2006) Nucleofection of primary neurons. Methods Enzymol 406:374-388
21. Gorman JM, Docherty JP (2010) A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders. J Neuropsychiatry Clin Neurosci 22:256-264
22. Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES, Körner I, Gan L, Chen S, Castro-Obregon S, Hammermann R, Wolf J, Müller-Hartmann H, Nix M, Siebenkotten G, Kraus G, Lun K (2004) New non-viral method for gene transfer into primary cells. Methods 33:151-163
23. Hara D, Fukuchi M, Miyashita T, Tabuchi A, Takasaki I, Naruse Y, Mori N, Kondo T, Tsuda M (2009) Remote control of activity-dependent BDNF gene promoter-I transcription mediated by REST/NRSF. Biochem Biophys Res Commun 384:506-511
24. Jiang X, Tian F, Du Y, Copeland NG, Jenkins NA, Tessarollo L, Wu X, Pan H, Hu XZ, Xu K, Kenney H, Egan SE, Turley H, Harris AL, Marini AM, Lipsky RH (2008) BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J Neurosci 28:1118-1130
25. Jope RS (1999) A bimodal model of the mechanism of action of lithium. Mol Psychiatry 4:21-25
26. Kairisalo M, Korhonen L, Sepp M, Pruunsild P, Kukkonen JP, Kivinen J, Timmusk T, Blomgren K, Lindholm D (2009) NF-kappaB-dependent regulation of brain-derived neurotrophic factor in hippocampal neurons by X-linked inhibitor of apoptosis protein. Eur J Neurosci 30:958-966
27. Karson CN, Newton JE, Livingston R, Jolly JB, Cooper TB, Sprigg J, Komoroski RA (1993) Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci 5:322-329
28. Kelly MW, Perry PJ, Holstad SG, Garvey MJ (1989) Serum fluoxetine and norfluoxetine concentrations and antidepressant response. Ther Drug Monit 11:165-170
29. Khundakar AA, Zetterström TS (2006) Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain Res 1106:12-20
30. Krause M, Jia Y (2005) Serotonergic modulation of carbachol-induced rhythmic activity in hippocampal slices. Neuropharmacol 48:381-390
31. Krishnan V, Nestler EJ (2010) Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 167:1305-1320
32. Leclere PG, Panjwani A, Docherty R, Berry M, Pizzey J, Tonge DA (2005) Effective gene delivery to adult neurons by a modified form of electroporation. J Neurosci Methods 142:137-143
33. Lipsky RH, Xu K, Zhu D, Kelly C, Terhakopian A, Novelli A, Marini AM (2001) Nuclear factor kappaB is a critical determinant in N-methyl-D-Aspartate receptor-mediated neuroprotection. J Neurochem 78:254-264
34. Malberg JE, Blendy JA (2005) Antidepressant action: To the nucleus and beyond. Trends Pharmacol Sci 26:631-638
35. McEwen BS (2005) Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism 54:20-23
36. Mueller RA, Lundberg DB, Breese GR (1981) Alteration of aminophylline-induced respiratory stimulation by perturbation of biogenic amine systems. J Pharmacol Exp Ther 218:593-599
37. Ozaki N, Chuang DM (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 69:2336-2344
38. Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacol 33:88-109
39. Popoli M, Mori S, Brunello N, Perez J, Gennarelli M, Racagni G (2001) Serine/threonine kinases as molecular targets of antidepressants. Implications for pathophysiology and pharmacological treatment. Pharmacol Therapeutics 89:149-170
40. Pruunsild P, Sepp M, Orav E, Koppel I, Timmusk T (2011) Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J Neurosci 31:3295-3308
41. Racagni G, Popoli M (2008) Cellular and molecular mechanisms in the long-Term action of antidepressants. Dialogues Clin Neurosci 10:385-400
42. Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ (2004) Hippocampal brain-derived neurotrophic factor expression following treatment with RBX, citalopram, and physical exercise. Neuropsychopharmacol 29:2189-2199
43. Ryan B, Musazzi L, Mallei A, Tardito D, Gruber SH, El Khoury A, Anwyl R, Racagni G, Mathé AA, Rowan MJ, Popoli M (2009) Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol 12:553-559
44. Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacol 62:63-77
45. Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20:727-740
46. Strauss WL, Layton ME, Hayes CE, Dager SR (1997) 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessivecompulsive disorder. Am J Psychiatry 154:516-522
47. Tabuchi A, Sano K, Nakaoka R, Nakatani C, Tsuda M (1998) Inducibility of BDNF gene promoter I detected by calcium-phosphate-mediated DNA transfection is confined to neuronal but not to glial cells. Biochem Biophys Res Commun 253:818-823
48. Tabuchi A, Nakaoka R, Amano K, Yukimine M, Andoh T, Kuraishi Y, Tsuda M (2000) Differential activation of brain-derived neurotrophic factor gene promoters I, III by Ca2+ signals evoked via L-Type voltage-dependent and N-methyl-D-Aspartate receptor Ca2+ channels. J Biol Chem 275:17269-17275
49. Tabuchi A, Sakaya H, Kisukeda T, Fushiki H, Tsuda M (2002) Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem 277:35920-35931
50. Takeuchi Y, Miyamoto E, Fukunaga K (2002) Analysis on the promoter region of exon IV brain-derived neurotrophic factor in NG108-15 cells. J Neurochem 83:67-79
51. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709-726
52. Tao X, West AE, Chen WG, Corfas G, Greenberg ME (2002) A calcium-responsive transcription factor, CaRE, that regulates neuronal activity-dependent expression of BDNF. Neuron 33:383-395
53. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: A critical overview. Pharmacol Rev 58:115-134
54. Tardito D, Musazzi L, Tiraboschi E, Mallei A, Racagni G, Popoli M (2009) Early induction of CREB activation and CREB-regulating signalling by antidepressants. Int J Neuropsychopharmacol 12:1367-1381
55. Thompson RM, Weickert CS, Wyatt E, Webster MJ (2011) Decreased BDNF, trkB-TK and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36:195-203
56. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, Persson H (1993) Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10:475-489
57. Timmusk T, Palm K, Lendahl U, Metsis M (1999) Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J Biol Chem 274:1078-1084
58. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14:51-59
59. Yoshii A, Constantine-Paton M (2010) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70:304-322
60. Wang JW, Dranovsky A, Hen R (2008) The when and where of BDNF and the antidepressant response. Biol Psychiatry 63:640-641
61. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME (2001) Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A 98:11024-11031